Literature DB >> 2515199

Determination of fluvoxamine in human plasma by high-performance liquid chromatography with ultraviolet detection.

J P Foglia1, L A Birder, J M Perel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2515199     DOI： 10.1016/s0378-4347(00)82635-3

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  7 in total

Review 1.  Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.

Authors:  C L DeVane
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

2.  Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.

Authors:  Helen Blair Simpson; Edna B Foa; Michael R Liebowitz; Jonathan D Huppert; Shawn Cahill; Michael J Maher; Carmen P McLean; James Bender; Sue M Marcus; Monnica T Williams; Jamie Weaver; Donna Vermes; Page E Van Meter; Carolyn I Rodriguez; Mark Powers; Anthony Pinto; Patricia Imms; Chang-Gyu Hahn; Raphael Campeas
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

Review 3.  Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Authors:  P Baumann
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

4.  The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.

Authors:  S Caccia; M Anelli; A M Codegoni; C Fracasso; S Garattini
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 5.  Clinical pharmacokinetics of fluvoxamine.

Authors:  E Perucca; G Gatti; E Spina
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

6.  A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.

Authors:  Helen Blair Simpson; Edna B Foa; Michael R Liebowitz; Deborah Roth Ledley; Jonathan D Huppert; Shawn Cahill; Donna Vermes; Andrew B Schmidt; Elizabeth Hembree; Martin Franklin; Raphael Campeas; Chang-Gyu Hahn; Eva Petkova
Journal:  Am J Psychiatry       Date:  2008-03-03       Impact factor: 18.112

7.  Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.

Authors:  Helen B Simpson; Edna B Foa; Michael G Wheaton; Thea Gallagher; Marina Gershkovich; Andrew B Schmidt; Jonathan D Huppert; Raphael B Campeas; Patricia A Imms; Shawn P Cahill; Christina DiChiara; Steven D Tsao; Anthony C Puliafico; Daniel Chazin; Anu Asnaani; Kelly Moore; Jeremy Tyler; Shari A Steinman; Arturo Sanchez-LaCay; Sandy Capaldi; Ivar Snorrason; Elizabeth Turk-Karan; Donna Vermes; Eyal Kalanthroff; Anthony Pinto; Chang-Gyu Hahn; Bin Xu; Page E Van Meter; Martha Katechis; Jennifer Scodes; Yuanjia Wang
Journal:  Behav Res Ther       Date:  2021-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.